CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load

Clinical Infectious Diseases

Volumn 46, Issue 8, 2008, Pages

  Andrade, Adriana ^a   Bailey, Justin R ^a   Xu, Jie ^a   Philp, Frances H ^a   Quinn, Thomas C ^a,b   Williams, Thomas M ^c,d   Ray, Stuart C ^a   Thomas, David L ^a   Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d TRICORE REFERENCE LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CD14 ANTIGEN; DIDANOSINE; ENDOTOXIN ANTIBODY; GAMMA INTERFERON; HLA B 5801 ANTIGEN; HLA B ANTIGEN; LAMIVUDINE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; NEF PROTEIN; POL PROTEIN; RITONAVIR; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA; VPR PROTEIN; ZIDOVUDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CRYOPRESERVATION; DISEASE COURSE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HLA TYPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MONOTHERAPY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; T CELL DEPLETION; VIRUS CULTURE; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; LYMPHOCYTE DEPLETION; MALE; VIRAL LOAD;

EID: 42549154422     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/529387     Document Type: Article

References (15)

1. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97:2709-14.
2. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature 2004; 432:769-75.
3. Blankson JN, Bailey JR, Thayil S, et al. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors. J Virol 2007; 81:2508-18.
4. Bailey JR, Williams TM, Siliciano RF, Blankson JN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203:1357-69.
5. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71.
6. Mellors JW, Kingsley LA, Rinaldo CR Jr., et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-9.
7. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-70.
8. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169:3400-6.
9. Saez-Cirion A, Lacabaratz C, Lambotte O, et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA 2007; 104:6776-81.
10. Greenough TC, Sullivan JL, Desrosiers RC. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999; 340:236-7.
11. Learmont JC, Geczy AF, Mills J, et al. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1: a report from the Sydney Blood Bank Cohort. N Engl J Med 1999; 340:1715-22.
12. Ho DD, Cao Y, Zhu T, et al. Idiopathic CD4+ T-lymphocytopenia - immunodeficiency without evidence of HIV infection. N Engl J Med 1993; 328:380-5.
13. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77:2081-92.
14. Choudhary SK, Vrisekoop N, Jansen CA, et al. Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease. J Virol 2007; 81:8838-42.
15. Casazza JP, Betts MR, Picker LJ, Koup RA. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy. J Virol 2001; 75:6508-16.